Abstract
Emerging evidence suggests that microbiota dysbiosis plays a critical role in the pathogenesis of endometrial cancer (EC), a leading cause of cancer-related deaths in women globally. This study investigated alterations in microbiota composition across different parts of the female genital tract in a Chinese cohort of 59 individuals (22 EC patients, 8 endometrial hyperplasia patients, and 29 benign controls). Using 16S rRNA sequencing, researchers identified specific taxa significantly enriched in the EC group, including Akkermansia muciniphila and Pseudomonas. These microbial shifts correlated with clinical markers such as fasting plasma glucose and hormone receptor expression. A machine-learning model based on vaginal swabs successfully distinguished EC patients from controls, suggesting a potential for non-invasive diagnostics.
Introduction
Endometrial cancer (EC) is often driven by factors like estrogen exposure, obesity, and chronic inflammation. While the human microbiome's role in various cancers is well-documented, research on the female reproductive tract has traditionally focused on the vagina or endometrium in isolation. This study addresses the "microbial continuum"—the gradient of bacteria from the lower tract (vagina) to the upper tract (uterus and fallopian tubes)—to determine if specific microbial patterns exist across these sites and if they could serve as biomarkers for early, non-invasive diagnosis.
Methods
The researchers conducted a cross-sectional study of 59 Chinese women, collecting samples from five anatomical sites: vaginal swabs (lower tract), and uterine swabs, fallopian tube swabs, peritoneal fluid, and endometrial tissue (upper tract). Bacterial communities were profiled using 16S rRNA sequencing of the V4 region on the Illumina MiSeq platform. Data were processed using QIIME2 and DADA2, with functional predictions inferred via PICRUSt2. Finally, a Random Forest model was trained on vaginal microbial profiles to evaluate diagnostic potential.
Results and Discussion
Taxonomic Shifts and Microbial Signatures
The study revealed distinct taxonomic shifts across the reproductive tract in EC patients. Notably, EC patients showed a significant decrease in Actinobacteriota (specifically Gardnerella) in the vagina, while the endometrium was enriched with Pseudomonas, Bacillus, and Streptomyces. Interestingly, Akkermansia muciniphila—typically considered a beneficial gut microbe—was significantly enriched in the vaginal microbiota of EC patients, suggesting site-specific roles for certain bacteria.
The Diversity Paradox
Unlike many disease states characterized by a loss of microbial diversity, EC patients exhibited increased microbial richness and diversity (alpha-diversity) in the vaginal site compared to benign controls. This finding highlights a unique microbial signature associated with the disease state in the lower reproductive tract.
Clinical and Metabolic Correlations
Microbial abundances were found to correlate with key clinical indicators. The abundance of Acinetobacter in the vagina was positively correlated with fasting plasma glucose levels, linking metabolic risk factors like diabetes to the reproductive microbiome. Additionally, Pseudomonas abundance in the endometrium correlated with the expression of estrogen and progesterone receptors, suggesting that the local hormonal environment may shape, or be shaped by, the microbiome to influence tumor progression.
Diagnostic Potential
A Random Forest model utilizing vaginal markers such as Mobiluncus, Peptoniphilus, and Porphyromonas achieved an Area Under the Curve (AUC) of 0.88. This suggests that a simple, non-invasive vaginal swab could potentially serve as an effective screening tool for endometrial cancer.
Conclusion
This study identifies distinct microbial signatures along the female reproductive tract that correlate with clinical and metabolic markers in endometrial cancer patients. While the findings are promising for future diagnostics, the study's cross-sectional nature and relatively small sample size necessitate further longitudinal research and multi-omics approaches to clarify the underlying molecular mechanisms and causal relationships.
Summary updated